43
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2529005
Genoplexus develops transformative treatments for devastating diseases, focusing on biotechnology.
- Haluk Germeyan: Co-Founder / CEO
About the Company
Genoplexus specializes in the development of transformative treatments aimed at addressing devastating diseases. With a focus on biotechnology, the company leverages the extensive operational and commercial experience of its team, which spans decades across various therapeutic areas. Genoplexus is committed to innovation in the field of life
sciences, aiming to create significant advancements in treatment options. The team at Genoplexus includes seasoned professionals with a deep understanding of biopharmaceuticals, emphasizing the importance of strategic partnerships and research in advancing their mission.